Guardant Health Inc (GH)
18.19
+0.84
(+4.84%)
USD |
NASDAQ |
Apr 29, 16:00
18.20
+0.01
(+0.05%)
Pre-Market: 08:28
Guardant Health SG&A Expense (Quarterly): 116.79M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 116.79M |
September 30, 2023 | 105.11M |
June 30, 2023 | 112.56M |
March 31, 2023 | 116.57M |
December 31, 2022 | 119.31M |
September 30, 2022 | 121.49M |
June 30, 2022 | 117.28M |
March 31, 2022 | 105.70M |
December 31, 2021 | 99.87M |
September 30, 2021 | 100.28M |
June 30, 2021 | 96.09M |
March 31, 2021 | 102.27M |
December 31, 2020 | 100.79M |
Date | Value |
---|---|
September 30, 2020 | 91.39M |
June 30, 2020 | 62.20M |
March 31, 2020 | 44.90M |
December 31, 2019 | 41.15M |
September 30, 2019 | 35.24M |
June 30, 2019 | 32.88M |
March 31, 2019 | 30.47M |
December 31, 2018 | 29.66M |
September 30, 2018 | 21.59M |
June 30, 2018 | 20.57M |
March 31, 2018 | 17.83M |
December 31, 2017 | 18.35M |
September 30, 2017 | 23.90M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
32.88M
Minimum
Jun 2019
121.49M
Maximum
Sep 2022
90.63M
Average
100.79M
Median
Dec 2020
SG&A Expense (Quarterly) Benchmarks
Exact Sciences Corp | 411.03M |
Illumina Inc | 485.00M |
Delcath Systems Inc | 6.963M |
CytoSorbents Corp | 10.56M |
Progyny Inc | 43.09M |